/
Log inGet free API keyAccount
Menu
InvestorsCompaniesFit CheckerDocsPricingGet free API key

Companies / HEPHAISTOS Pharma

HEPHAISTOS Pharma

Company

HEPHAISTOS is a biopharmaceutical company developing 3rd generation innate immune boosters designed to convert myeloid-rich tumors into immunotherapy responsive tumors.

Healthcare & Biotech

HEPHAISTOS Pharma has 2 investors on file, among them Noshaq and XISTA Science Ventures. Its site was last checked 6 Nov 2026: site answers.

hephaistos-pharma.com

Investors

2 investors on file
InvestorEvidenceType
NoshaqPortfolio pageInvestor
XISTA Science VenturesPortfolio pageVenture capital

More from Noshaq

186 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (23%), AI & Machine Learning (19%), Industrial & Manufacturing (13%).

Brenus PharmaBrenus Pharma develops off-the-shelf immunotherapies for solid tumorsExeVir BioExeVir Bio develops novel antibody therapies to prevent and treat infe…Model HealthModel Health converts smartphone videos into validated, decision-ready…NovadipNovadip Biosciences develops regenerative tissue products for bone and…ObiObi Health connects patients and clinics, making fertility care simple…

See Noshaq's full profile · Who invests alongside it

More from XISTA Science Ventures

15 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (29%), Industrial & Manufacturing (29%), AI & Machine Learning (14%).

AmplifoldAmplifold develops DNA origami technology to amplify the signal of lat…Invisible-Light LabsInvisible-Light Labs provides nanomechanical infrared analysis technol…collimatehealth.comCollimateHealth develops microbeam radiation technology for cancer tre…Epitome TherapeuticsEpitome Therapeutics is developing a next-generation epigenome editing…Syntropic MedicalSyntropic Medical develops a medical device to treat Major Depressive …

See XISTA Science Ventures' full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get HEPHAISTOS Pharma and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Noshaq adds a company.

Work email, sign-in link by email. Already have an account? Log in
Your API keyRead the docs
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/hephaistos-pharma.com/investors

# also
GET /v1/companies/hephaistos-pharma.com
GET /v1/companies/hephaistos-pharma.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing